HEXARELIN 5 mg

for: GH Release & Muscle Strength.

Hexarelin (5mg) is a specialized research hexapeptide utilized primarily to investigate potent growth hormone stimulation and cardiovascular protective mechanisms. As a highly stable analog of Ghrelin, it is a selective agonist of the Growth Hormone Secretagogue Receptor (GHS-R1a). Dragon Pharma provides Hexarelin 5mg at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of endocrine research and cardiovascular science, Hexarelin stands out as one of the most potent synthetic growth hormone secretagogues (GHS) available. Known scientifically as a modified version of GHRP-6, this compound has become a fundamental tool for investigators exploring the limits of pituitary GH release and the secondary protection of cardiac tissue. Dragon Pharma provides Hexarelin 5mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Peptide capable of producing reproducible and accurate data in complex metabolic and cardiac models.

As scientific inquiry into heart failure, muscle wasting (cachexia), and age-related endocrine decline expands, the need for reliable GHS-R agonists like Hexarelin has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of Hexarelin 5mg.

Molecular Characteristics and Chemical Profile

The structural integrity of Hexarelin is characterized by its resistance to dipeptidyl peptidase-4 (DPP-4) degradation, providing it with a superior pharmacokinetic profile compared to natural ghrelin.

• Chemical Identity: Hexarelin (Examorelin)
• Sequence: His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2
• Molecular Formula: C47H58N12O6
• Molecular Weight: 887.04 g/mol
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Lyophilized powder
• Manufacturer: Dragon Pharma

Research Applications

The peptide is utilized in various scientific investigative domains, including:

• Pituitary Signaling: Mapping the maximal secretory capacity of growth hormone somatotrophs.
• Cardioprotection: Investigating the reduction of apoptosis in cardiomyocytes following ischemic events.
• Skeletal Muscle Homeostasis: Studying the modulation of muscle fiber atrophy and nitrogen retention.
• Lipid Metabolism: Assessing the impacts on adipose tissue distribution and fatty acid oxidation.
• Bone Density: Evaluating the downstream effects of the GH/IGF-1 axis on osteoblast activity.

Pathway and Mechanistic Context

The core value of Hexarelin 5mg in a laboratory setting is its ability to manipulate the GHS-R1a receptor with higher intensity than almost any other peptide in its class. Unlike GHRH-based analogs, Hexarelin provides a rapid, robust "pulse" of growth hormone by bypassing the need for hypothalamic signaling.

The GHS-R1a and CD36 Axis

Upon activation by Hexarelin, the GHS-R1a receptor triggers a massive influx of intracellular calcium in the pituitary, leading to immediate GH exocytosis. Additionally, Hexarelin is unique for its interaction with CD36 receptors found in the heart and vasculature.

Key Mechanistic Shifts:

• Maximal GH Stimulation: Hexarelin is often used as a "positive control" in GH research due to its ability to elicit the highest level of GH release among hexapeptides.
• Cardiovascular Stability: It is researched for its ability to improve left ventricular function and increase stroke volume in models of myocardial injury.
• Somatostatin Antagonism: Hexarelin effectively inhibits somatostatin, the "off-switch" for growth hormone, ensuring a sustained signaling window during experimental protocols.

Primary Research Applications

1. Cardiovascular Preconditioning and Repair

Hexarelin is heavily utilized in studies involving myocardial infarction and heart failure. Because it binds to cardiac receptors, it provides a unique framework for investigating how to protect heart cells from oxidative stress and programmed cell death (apoptosis).

2. Muscle Atrophy and Cachexia Models

Known in research circles for its anabolic signaling, Hexarelin is used to observe how tissues adapt to acute increases in the GH/IGF-1 axis. Investigators study changes in muscle cross-sectional area and the inhibition of protein degradation pathways like MuRF1.

3. Neuroendocrine Diagnostic Research

In pituitary research, Hexarelin is used to assess the functional reserve of the somatotropic system. Investigators study how the pituitary responds to potent chemical stimuli to better understand the mechanics of growth hormone deficiency.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with a rigorous manufacturing process. Hexarelin 5mg is produced under strict laboratory conditions to ensure that the compound remains stable and potent.

• Lyophilization for Stability: The compound is supplied in a freeze-dried form. This process removes moisture while preserving the molecular structure, ensuring the peptide remains stable during transit.
• Rigorous Analytical Verification: To guarantee a purity level of 99% or higher, every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm that the molecular signature matches the verified Hexarelin profile.

Product Usage Disclaimer: This product is intended for laboratory and in-vitro research use only. It is not approved for human or veterinary application. Must be handled by qualified professionals. Not for drug, food, or cosmetic purposes. Misuse or misbranding is strictly prohibited.

Author:

All information was searched/edited by Dr. S. Edwin, and Dr. E. Croft who holds a doctorate from Case Western Reserve University School of Medicine